secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuwellis, Inc. (NUWE)
CIK:        0001506492
Form:       8-K
Filed at:   2026-08-13T20:38:45+00:00
Accession:  0001140361-26-032838
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuwellis Q2 net sales up 14% to $2.0M; gross margin 76% vs 56%; CEO appointed
-----------------------------------------------------------------------------

- Net sales $2.0M, +14% YoY; U.S. revenue +17%; H1 sales $4.4M, +20%.
- Gross margin improved to 76% from 56% on pricing, mix, contract manufacturing.
- Net loss $4.8M incl. $1.7M non-cash warrant expense; cash $3.9M at June 30.
- Raised ~$12.7M gross proceeds from June offering and July financing/warrant exercises.
- Appointed Mike McCormick CEO effective June 30; FDA pre-sub for Aquadex label to 5kg.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506492/000114036126032838/0001140361-26-032838-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506492/000114036126032838/ef20080204_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-032838

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer